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Executive Summary 
 
Telehealth is seen as a way of improving access to patient care for long term 
conditions and there is a considerable volume of published literature available. This 
report provides an overview of the best available evidence by summarising recent 
systematic reviews.  
 
It was found that there is more evidence for some conditions than others, but on the 
whole the trends are largely positive suggesting that telehealth is effective in: 
 
•  Reducing patient mortality and hospital admissions for chronic 
 heart failure 
•  Reducing hospital admissions for COPD 
•  Reducing blood pressure in hypertension, improving glycaemic 
 control in diabetes and reducing symptoms in asthma 
 
For a wide range of other clinical outcomes and across conditions, telehealth seems 
to be as good as usual patient care, suggesting that it is fulfilling its promise of 
increasing access to services.  
 
Patients appear to be satisfied with telehealth services across a wide range of 
conditions, although there may be a need for considering individual patient 
requirements in some contexts. 
 
However there is a debate regarding the quality and nature of evaluations of 
telehealth systems and this cannot be ignored.  Repeated systematic reviews have 
commented on the quality of evaluations.  
 
Future evaluations should incorporate mixed methods or a realist approach to 
examine what works for whom and why; this may well provide the way forward in 
examining in more depth the more meaningful effects of telehealthcare. 
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Introduction 
This report seeks to provide a quick but rigorous literature review examining the 
clinical outcomes, cost effectiveness and patient views of telehealth systems for long 
term conditions.  
 
Telehealth is a wide field and recent years have seen an increasing amount of 
published studies seeking to ascertain its effectiveness [1]. There are many 
definitions of telehealth [2] and within the literature the terms telecare, telemonitoring 
and telemedicine are often used interchangeably. Papers on the topic frequently 
discuss and study a range of systems together. This myriad of definitions together 
with a high volume of heterogeneous studies makes reviewing and making sense of 
the evidence on the topic a challenge. This is further complicated by the debate 
surrounding the quality of research in this field and the shortcomings of various 
methodologies for assessing telemedicine [3].  
 
For the purposes of this report, the starting point was a wide and systematic search 
of the published literature using “the management of long term conditions via remote 
monitoring of vital signs using equipment in the patients’ home” 
(http://www.tunstallgroup.com/) as a definition. Although a broader view of telehealth 
might include digital images, audio and videoconferencing for examination or 
consultation, the Tunstall definition is consistent with the UK Department of Health 
definition: ‘Electronic sensors or equipment that monitors vital health signs remotely, 
e.g. in your own home or while on the move. These readings are automatically 
transmitted to an appropriately trained person who can monitor the health, vital signs 
and make decisions about potential interventions in real time, without the patient 
needing to attend a clinic’ [4].  
 
Telehealth, as a modality for the delivery of health services and information, is being 
implemented in many regions across the world and is seen as a way of providing or 
improving access to quality health services, thereby leveling the health care playing 
field in deprived or geographically remote areas. The Department of Health has 
signalled its commitment to delivering telehealthcare through the launch of the 
3millionlives initiative [6] in January 2012 which is designed to deliver telehealth and 
telecare to three million people in the next five years.  Perhaps the largest study 
around telehealth has been the Whole System Demonstrator project, which sought to 
provide a robust evidence-base for telehealth (and telecare: ‘Personal and 
environmental sensors in the home that enable people to remain safe and 
independent in their own home for longer. 24 hour monitoring ensures that should an 
event occur the information is acted upon immediately and the most appropriate 
response put in train’) [4]. This large-scale, multi-site randomised controlled trial was 
launched in 2008 and included 6191 patients with diabetes, COPD or heart failure. 
The early results from the trial indicated that ‘if used correctly telehealth can deliver a 
15% reduction in A&E visits, a 20% reduction in emergency admissions, a 14% 
reduction in elective admissions, a 14% reduction in bed days and an 8% reduction 
in tariff costs. More strikingly they also demonstrate a 45% reduction in mortality 
rates’.  
 
This overview will draw on evidence from a wider literature base in an attempt to test 
out the generalisability of these early results.   
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Methods 
A systematic literature search from 2000 onwards was undertaken using a 
range of electronic databases, selected to cover as broad a range of perspectives in 
the time frame available (see Appendix 1). To reduce the volume of literature that 
could potentially be included, the review criteria (Table 1) were applied in two stages 
(initial and revised).  A high number of systematic reviews on the various aspects of 
telehealth were available, including a recent overview of systematic reviews [3, 5]. 
The breadth, depth and academic rigour of this recent overview enabled the 
team to move forward from this starting point and focus their research on 
subsequent systematic reviews in order to provide a broad overview of the 
best evidence available – a review of reviews.  
 
Initial Inclusion Criteria Initial Exclusion Criteria 
Involved studies which met the definition: 
“The use of telecommunication 
technologies by patients for the timely 
transmission of data from a home to 
health care service centre” and 
1. Required the patient or carer to 
periodically measure 
physiological indicators and/or 
record their symptoms/vital signs 
in a standardized format 
2. Use telecommunication 
technologies that manually or 
automatically transferred data 
from patients home to health care 
service 
3. Led to review of patients health 
status data 
4. Involve a response when the data 
crossed a predefined threshold 
 
Measurement of vital signs was taken by 
health care professionals, decision 
modelling, telecommunication between 
two clinicians, remote consultation 
Any long term condition Acute conditions 
Collected data on the following outcomes 
– health benefits, mortality, morbidity, 
QoL, costs, unplanned re-admissions 
A&E visits, ambulance call outs, length of 
stay, out patient attendances, workforce 
efficiencies, clinical parameters for 
particular conditions (eg blood pressure 
for hypertension) 
Clinical outcomes not reported 
UK or international  
2000 onwards  Before 2000 
Revised inclusion criteria Revised exclusion criteria 
Systematic reviews or Qualitative studies 
of patient experience or economic 
evaluations 
Non systematic literature reviews, 
individual quantitative studies (RCTs, 
quasi experimental, evaluations) 
Post 2010  Published prior to 2010 
 
Table 1: Inclusion/Exclusion Criteria 
 
Figure 1 demonstrates the methods used to manage the literature via a searching 
and screening process to obtain the final set of systematic reviews included in this 
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report. To reduce bias in the selection process all titles and abstracts were screened 
by two people, potentially relevant articles were obtained and screened by one of a 
team of three people using agreed criteria, data for those meeting the inclusion 
criteria were extracted by one of a team of four people following an agreed approach 
onto predefined forms. Extracted data was combined onto a series of data tables and 
used to provide the narrative synthesis. Full details of searches can be found in 
Appendix 1. 
 
 
 
Figure 1: Flow diagram of literature search and screening and exclusion 
process 
 
3433 papers retrieved from database searches and screened by title and abstract 
Excluded on basis of title 
and abstract didn’t meet 
initial inclusion criteria 
n=2966 
467 papers meeting initial inclusion criteria for full text screening  
19 systematic 
reviews  
Excluded as didn’t meet 
revised inclusion criteria 
n= 420 
Excluded as unable to 
obtain in time frame  
n=19  
28 papers meeting revised criteria, extracted and included in review 
3 reports of 
economic 
evaluations 
6 studies 
relating to 
patient 
experience 
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Results 
Overview of the evidence 
A total of 467 individual papers were identified as potentially relevant 
for inclusion in this literature review (following the initial criteria in Table 1). This 
included a high number of systematic reviews of various aspects of telehealthcare, 
including an overview of reviews of telemedicine up to 2010 [3, 5]. In order to fully 
utilise the short time frame available the overview [5] [3] was employed as a starting 
point, and is described separately below. Then, a narrative summary of the evidence 
from 19 systematic reviews, together with three economic evaluations and six patient 
view studies published since 2010 are presented for a wide range of clinical 
outcomes.  
 
The quality of the reviews included in this report was mixed from high quality 
Cochrane reviews [8-11] and high level overviews [1], to smaller scale reviews limited 
to one source of evidence [12].  A number of the reviews highlighted concerns about 
the quality of evidence available [1, 3, 13], this included the short term nature of the 
evaluations undertaken, the small sample sizes, the wide range of outcomes 
collected, the heterogeneous nature of the studies (making studies difficult to 
compare); and a lack of patient and economic perspectives. Invariably these factors 
need to be taken into account when considering the evidence and conclusions that 
are reported below.  An overview of the studies included in this report is presented in 
Appendix 2. 
 
 
Evidence for effectiveness of telehealth prior to 2010 
A large scale EU funded project provided an overview of the evidence up to 2010 [3, 
5]. The authors examined 80 systematic reviews on the effectiveness of telemedicine 
[5] and 50 systematic reviews to provide guidance on methodology [3]. Of these 
reviews, 26 met the definition of telehealth that we have used above, 9 suggested 
that the telehealth systems were effective, 8 suggested that telehealth had promise, 
as they demonstrated equivalent results to usual care and 9 provided limited and 
inconsistent evidence regarding telehealth. Economic effectiveness and patient 
satisfaction were also covered with 9 relevant papers suggesting that there is a lack 
of knowledge and understanding regarding costs around telehealth and 3 papers 
providing a mixed view of the evidence regarding patient satisfaction. For outcomes 
of interest here, the evidence prior to 2010 demonstrated a reduction in mortality and 
admissions in relation to chronic heart failure, as well as indicating that telehealth 
systems were feasible to use and that they were acceptable to patients. The study 
concluded that there was a need for larger scale studies of the predefined effects of 
controlled telemedicine interventions but acknowledged that such studies cannot 
address all emerging questions about telehealth. Future studies should consider 
telehealth as a complex intervention and utilise mixed method approaches to 
evaluation, which consider the outcomes relevant to the specific context. It was also 
recommended that assessments, which engage all stakeholders and consider all the 
economic benefits should be conducted in natural settings. 
 
 
Evidence of effectiveness post 2010 
Clinical outcomes 
Mortality  
Of the 19 reviews included here, eight examined whether telehealth interventions 
made a difference to mortality rates; For heart failure four reviews suggested that 
telehealth reduced mortality [11, 14-16] and a further two reported no differences 
between telehealth and the usual patient care [12, 13]. With regard to Chronic 
Obstructive Pulmonary Disease (COPD) two reviews reported no shown differences 
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between telehealth and the usual patient care for COPD [7, 9]. 
 
Hospital admissions 
Nine reviews examined whether telehealth made a difference to patient hospital 
admission rates. For heart failure, four reviews demonstrated a reduction in hospital 
admissions [7, 11, 12, 16] and two showed no difference between telehealth and the 
usual care for admissions [13-15]. In the case of COPD, two reviews suggested that 
telehealth was effective in reducing hospital admissions [9, 17].  
 
Bed days  
Five of the reviews reported on bed days taken or length of stay in hospital for the 
patient. In the case of heart failure the conclusions appear to be mixed, with two 
reporting a reduction in the length of in-patient stay [12, 16] and two reporting no 
difference [11, 14]. Polisena et al [17] also reported a neutral effect for length of stay 
in COPD. 
 
A&E 
Only one review examined patient visits to A&E [14] and this review reported no  
difference between the usual level of care and telehealth for congestive heart failure.  
 
GP visits 
The evidence for the effectiveness in terms of GP visits is neutral with three studies 
showing no difference between telehealth and usual patient care for hypertension 
[18], congestive heart failure [16] and asthma [10]. These findings are illustrated in 
Table 2  
 
There was more evidence available for congestive heart failure than other long-term 
conditions.  Overall the evidence suggests that telehealth is effective at reducing 
mortality and hospital admissions for congestive heart failure. With regard to other 
outcomes, the evidence is suggesting that Telehealth is as effective as usual care for 
reducing the length of in-patient stay; A&E visits or visits to the GP. For other 
conditions, such as COPD two reviews have suggested that telehealth reduces 
patient admissions and a range of studies suggest that telehealth is as effective as 
usual care for mortality and bed days. 
 
 
Key points – clinical outcomes 
• Evidence suggests that Telehealth is more effective than usual care for 
  some outcomes and as effective as usual care for others.   
• For congestive heart failure telehealth reduces mortality and hospital 
  admissions, and is as effective as usual care for bed days, visits to the 
  GP and A&E visits (4 reviews) 
• For COPD telehealth reduces hospital admissions and is as effective 
  as usual care in terms of patient mortality, admissions and bed days (2 reviews) 
 
 
Condition specific outcome measures and quality of life 
Of the 19 systematic reviews, specific outcomes for particular conditions were 
reported in six and a further six reported on quality of life indicators more generally. 
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For hypertension, three reviews reported that telehealth was effective in reducing 
blood pressure [13, 18, 19] and one found no difference between telehealth and the 
usual method of care. 
 
 
One review reported an increase in the use of antihypertensive drugs [19]. For 
diabetes two reviews reported improvements in glycaemic control [13, 20] yet no 
evidence was found of improved BMI or self-efficacy [20]. For asthma, significant 
improvements in peak expiratory flow were reported in one review [13] and similar 
results to the usual patient care in another [10]. Two of the reviews reported 
reductions in the symptoms of asthma [7, 13] and evidence of similar results to the 
usual patient care for quality of life more generally for asthma [10] and COPD [17]. 
 
Heart failure results are similarly mixed with one review suggesting that seven 
studies reported no difference in patient quality of life and five studies reporting 
positive increases in patient quality of life [16]. A further review reported that two 
thirds of studies suggested telehealth made no difference to medication adherence 
and one third of the studies reported that telehealth improved adherence and quality 
of patient life [14]. Wooton, in an overview of systematic reviews and randomised 
controlled trials for a number of long term conditions [1], concurs with these mixed 
results from different studies suggesting that the evidence for this wide range of 
outcomes is “weakly positive” in favour of telehealth. These results are illustrated in 
Table 3. 
 
 
Key points – condition specific outcomes 
• Telehealth is effective for reducing blood pressure in hypertension (3 reviews), 
   improving glycaemic control in diabetes (2 reviews) and reducing symptoms 
   in asthma (2 reviews)  
• Telehealth can be as effective as usual care for generally improving 
  quality of life across a range of conditions 
 
 
Economic evaluations 
Four of the systematic reviews reported on outcomes relating to costs [7, 9, 11, 14] 
and a further three papers specifically focused on costs and the economics of 
telehealth interventions [21-23]. For COPD two studies [7, 9] found limited evidence 
that telehealth was associated with reduced costs, however it was unclear which 
elements were included in the analysis. Similar evidence was also found in studies 
relating to heart failure [11, 14]. One study [21] derived an economic model in relation 
to heart failure which suggests that telehealth results in fewer hospital admissions 
and thus leads to cost savings, but again it was unclear which elements were 
included. Madsen [23] reported that medication and consultation costs were reduced 
for blood pressure monitoring when utilising telehealth, but these benefits were offset 
by the costs of implementing the necessary equipment. Similar findings were found in 
relation to diabetes [22], although the US context in this study may limit the 
applicability of these findings. These findings are very much in line with previous 
studies [1, 5] which found limited evidence on the cost effectiveness of telehealth, 
due to the nature of the evaluations which have been undertaken. One offered advice 
for future studies [5] including the need to develop studies which take into account 
multiple perspectives such as societal and organisational costs to provide a more 
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accurate picture of the economic benefits of telehealth. 
 
 
Key points – economic evaluations 
•  There is  some evidence that telehealth can reduce  costs, however it is   important 
to bear in mind the costs of implementing the systems 
    when costs are calculated 
•  Much more research on the economics of telehealth interventions is 
   needed. This should include cost benefit analyses which take into 
   account a wide range of perspectives 
 
 
 
Patient views  
A range of evidence was found relating to patient views of telehealth. Five of the 
systematic reviews included a patient satisfaction component [14, 16-18, 20], one 
review focused solely on patient satisfaction studies [24] and five other individual 
studies were extracted in line with inclusion criteria [25-29]. All reported positive 
effects of patients’ satisfaction with telehealth, although one review noted that the 
evidence was characterised by poorly constructed questionnaires [24] and another 
suggested that implementation of telehealth should be around patients’ specific 
needs for example those who were anxious may have different requirements [26].  
 
Two in-depth qualitative studies [28, 27] provided a wider perspective and clearly 
illustrated the barriers and success factors involved in using and implementing 
telehealth systems from both patients’ and an organisational perspective. The 
evidence for patient satisfaction was most established in relation to heart failure with 
four studies reporting patient satisfaction [14, 16, 24, 27] including the acceptance of 
and confidence with the technology [14] and an increased awareness and confidence 
about their health condition [27]. Two further studies [18, 25] also demonstrated that 
patients accepted and were confident in using telehealth systems in relation to blood 
pressure monitoring for hypertension. 
 
A qualitative study which covered a range of conditions [28] provided an insight into 
patients’ perspectives of telehealth and found that patients had learned to use the 
equipment by trial and error; tended to comply with the equipment rather than it 
empower them and tended to think the system did the work of healthcare 
professionals. Patients also reported feeling less of a nuisance and appreciated the 
continuity of care and easier access to healthcare professional advice. An insight into 
professional and organisational issues around implementing telehealth arose from 
two studies suggesting that telehealth changes the workflow and relationships 
between clinicians and patients [27] and that a paradox of the reliance and 
acceptance of telecare is the creation of new relationships and dependencies [28].  
An overview of the qualitative studies can be found in Table 4. 
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Key points – patient views 
•  Patients appear to be satisfied with telehealth services across a wide range of   
conditions. 
• More in-depth studies of patient experience would provide an insight into 
organisational and professional factors involved in implementing telehealth 
systems and help improve the quality of any future evaluations to ensure that 
   more meaningful outcomes are measured. 
 
 
Discussion 
Systematic reviews provide a comprehensive overview of the best quality evidence 
available on a topic area. By including only systematic reviews in this report, we 
aimed to provide an overview of the best available evidence for telehealth. The 
volume of evidence on telehealth is considerable and on the whole is positive [1, 13], 
providing either favourable clinical outcomes or demonstrating that telehealth is at 
least as good as conventional care. 
 
We found a number of good quality systematic reviews but even well conducted 
systematic reviews are dependent on the evidence available. As with previous 
reviews [1, 5, 13] the evidence available on telehealth was found to be characterised 
by; short-term small evaluations, small sample sizes, inconsistent collection of 
outcome measures, varying definitions of telehealth and varying focus of reviews 
(making comparison between studies and reviews difficult). Clearly these factors 
need to be taken into account when interpreting the conclusions from this overview 
and could be the reason why reviews on the same topic, draw different conclusions.  
 
However two reviews sought to address these issues and examined shorter [11] or 
larger scale [13] studies separately but still found similar trends in the evidence. A 
further concern is that telehealth is frequently compared with usual patient care, but 
this may not be the most appropriate comparison, as the telehealth intervention may 
well be very different from the usual care provided, and it could be said that any 
intervention which included more frequent monitoring of patients would lead to 
improved outcomes and increased costs. Future studies should compare two 
systems rather than telehealth against usual care in order to mitigate against this 
issue [13].  
 
Within the time available, it was not possible to conduct detailed critical appraisals of 
the studies located, this overview is therefore limited in that it relies on the authors 
findings and conclusions, rather than providing an unbiased judgement on the quality 
of each study. Limiting the overview to systematic reviews also means that some of 
the more recent studies may not have been included due to delays in the publishing 
process. A separate list of the most recent studies whose results may not be 
included has been located in Appendix 3. Furthermore there are many local 
evaluations of telehealth which may have been available outside the published 
literature. No attempt was made to locate or include these in this review. 
 
 
Conclusions 
Telehealth is seen as a way of improving access to patient care for long term 
conditions and there is a considerable volume of published literature available. This 
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report provides an overview of the best available evidence by summarising recent 
systematic reviews.  
 
There is more evidence for some conditions than others, but on the whole the trends 
are largely positive suggesting that telehealth is effective in: 
 
•  Reducing patient mortality and hospital admissions for chronic 
 heart failure 
•  Reducing hospital admissions for COPD 
•  Reducing blood pressure in hypertension, improving glycaemic 
 control in diabetes and reducing symptoms in asthma 
 
Furthermore for a wide range of other clinical outcomes and across conditions, 
telehealth seems to be as good as usual patient care, suggesting that it is fulfilling its 
promise of increasing access to services.  
 
Patients appear to be satisfied with telehealth services across a wide range of 
conditions, although there may be a need for considering individual patient 
requirements in some contexts. 
 
These conclusions are broadly in line with the early results from the large Whole 
Systems Demonstrator project [4] noted in the introduction and suggest that these 
are potentially more generalisable. 
 
However the debate regarding the quality and nature of evaluations of telehealth 
systems cannot be ignored, as repeated systematic reviews have commented on the 
quality of evaluations. In-depth studies of patients’ experiences have provided an 
insight into the organizational and professional factors involved in implementing 
telehealth systems.  Examining these factors more carefully may help implement 
telehealth systems from all stakeholders perspectives evaluations which incorporate 
mixed methods or a realist approach to examine what works for whom and why, may 
well provide the way forward in examining in more depth the more meaningful effects 
of telehealthcare. 
Author Year Condition Mortality Readmissions Bed days A&E visits Visits to GP 
Abudagga, 
et al 
2010 Coronary Not Assessed Not assessed Not Assessed Not Assessed Neutral.  Office visits 
frequency did not 
change 
Anker, et 
al 
2011 Coronary Neutral.  Meta analysis shows 
a RR=0.66. More recent studies 
not included in any meta-
analysis showed no significant 
differences 
Down.  Meta-analysis showed a reduction in 
CHF admissions. RR= 0.79 More recent (not in 
meta-analysis)  non-invasive RCTs showed no 
significant difference and 1 invasive trial 
demonstrated a significant reduction in 
admissions in the TM group. 
Down. 1 RCT 
concluded that the 
duration of hospital 
stays was reduced 
compared to the 
usual care. (9.1 vs 
3.8 days) 
Not Assessed Not assessed 
Bolton, et 
al 
2011 COPD Neutral. 1/6 studies assessed 
and  found no change. 
Down. 4/6 studies found reduction in 
admission. Unclear as to the cause of the 
admission 
Not Assessed Not Assessed Not Assessed 
Clarke et 
al 
2011 Coronary Down.  Overall risk ratio 0.77.  Neutral.  No change in all cause admission 
RR=0.99. Drop in CHF admission RR=0.73 in 
the TM group. Over time the intervention had 
no effect on admissions. 
Neutral. 7/9 studies 
reported no change. 
2/9 reported 
reduction. No meta-
analysis  
Neutral. RR=1.04 Not Assessed 
de Waure, 
et al 
2012 Coronary Down. In-hospital mortality 
reduced 35%. One study 
reported all cause mortality, not 
just due to MI. 2 studies 
reported 12 month survival in 
which mortality more than 
halved. 
Not Assessed  Not Assessed Not assessed Not Assessed 
Inglis, et al 2011 Coronary Down. 34% reduction in risk of 
mortality with TM.  
Down. TM reduced CHF hospitalisations by 
21% 
Neutral. No reported 
change with TM 
Not assessed Not assessed 
McLean, 
et al 
2011 COPD Neutral.  Insignificant change in 
odds ratio (1.05 p=0.86) 
Down.  Odds ratio of 0.46 compared to 
control. Likewise a lower odds of being 
discharged to a higher level of care (OR:0.29).  
Not Assessed Down. Meta-analysis 
Less likely to attend 
emergency dep't than 
control (odds 
ratio:0.27). Additional 
studies also 
demonstrated that 
control group patients 
are more likely to 
attend. Conversely 
one study reported a 
greater average visits 
Not Assessed 
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Table 2: Clinical Outcomes 
 
Neutral = outcome was reported in the review but no statistical difference was found between the interventions, ie the effects were the same usually between the intervention and usual care.  
Alternatively there were conflicting results between studies with some reporting positive effects and some no change or negative. 
Up/Down = outcome was reported in the review, a statistical difference was reported. 
Not Assessed = review didn’t examine this outcome 
 
by the intervention 
(1.79) than the 
control (1.53). 
Pare et al 2010 Diabetes, 
Asthma, 
Hypertension, 
Heart Failure 
Neutral.  Heart failure studies 
were equivocal and mortality 
didn’t differ between control and 
intervention groups 
Neutral.  Heart failure studies were equivocal 
and no statistical differences were found 
between intervention and control groups 
Not Assessed Not Assessed Not Assessed 
Polisena, 
et al 
2010 Coronary Down. All deaths RR=0.64. 
RCTs only RR=0.60 
Down. All cause hospitalisations RR=0.77 
RCTs only RR=0.79. Due to substantial 
heterogeneity there was no meta-analysis on 
total hospitalisation, the majority reported 
reduced hospitalisation in the TM condition. 
Specific to CHF, 2 studies found the TM group 
had increased hospitalisation where as 2 
studies concluded the opposite.   
Down. Reduced bed 
days in the majority 
of studies in the TM 
group compared to 
control. Pre-post 
studies showed 
reduced bed day post 
intervention. One 
study reported 
increase in bed days 
in the TM compared 
to control. Specific to 
CHF TM resulted in 
reduced bed days. 
Down. No meta-
analysis. Reduced 
emergency visits in 
the TM group  
compared to the 
control. Likewise 
reduced visits pre 
compared to post TM 
intervention. One 
study however found 
the TM group had 
higher admission 
than the control and 
one study found no 
difference. 
Neutral. Outpatient 
visits 2 studies 
concluded that TM 
reduced visits where 
as two concluded the 
opposite. 
Polisena, 
et al 
2010 COPD Not Assessed Down. Home telemonitoring had fewer 
hospital admissions than those in usual care 
groups.  Telesupport also reported lower 
hospitalisations. 
Neutral. 1 
observational study 
reported more bed 
days in the home 
telemonitoring than 
usual care4. 2 
observations studies 
reported reduced bed 
days compared to 
usual care. Only one 
study reported a p 
value.   
Down. 1 study 
reported a lower 
number of admission 
post TM intervention. 
Up. One 
observational study 
found greater mean 
GP visits. Again no p 
value 
One observational 
study reported lower 
mean home visits 
compared to usual 
care . No p value 
reported. 
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Table 3: Condition specific outcomes and quality of life 
Author Year Condition Clinical outcome measures QOL Other outcome 
measure 
Other outcome 
measure 
Abudagga,  et al 2010 Coronary Down. Reduced systolic and diastolic BP. 4 studies used 
24-h ambulatory BP monitoring (ABPM)and  reductions 
were statistically significant (SBP ranging from 2.8 to 
11.9mm Hg and DBP from 2.0 to 6.6mm Hg). For office-
based readings, BP was reduced at a statistically 
significant level across these studies, with declines ranging 
from 3.9 to 13.0mm Hg for SBP and from 2.0 to 8.0mm Hg 
for DBP 
Neutral. Quality of life 
did not change in 3/4 
studies 
None Assessed  
Bolton, et al 2011 COPD Down. Excaberations:2/4 reported and were statistically 
significantly reduced. 
Neutral. Quality of Life; 
1/2 reported significant 
improvement in TM 
group 
  
Clarke, et al 2011 Coronary Not Assessed Up. Quality of life. 
Scores increased in the 
TM group. Only one 
study did not report a 
improvement of quality of 
life. 
Down.  Cost 4/6 studies 
reported decreased costs 
Neutral.  Medication 
adherence. 2/3 no 
difference. 1/3 improved 
adherence.  
Holtz, et al 2012 Diabetes Down. HbA1c improved in 85% of cases measured.  Only 
3 studies significant differences 
Neutral. BMI no change  Neutral. Self efficacy: no 
change  
Up. Knowledge improved 
in 2 studies 
Inglis, et al  2011 Coronary Not Assessed Up. Three TM studies 
reported an improved 
quality of life.  
Down.  Cost decreased 
in 2/3 studies 
 
Mc Clean, et al 2011 Asthma Neutral. No significant changes in FEV1 or FVC. Not Assessed   
Omboni & Guarda 2011 Hypertension Down. Ambulatory and office systolic Bp decreased in TM 
group compared to control; office Diastolic BP decreased 
in TM compared to control. Ambulatory Diastolic BP did 
not vary between TM and control groups. There was a 
greater improvement in the TM group regarding BP 
normalisation.   
Up. Increase in 
antihypertensive drugs in 
TM group 
  
Pare, et al 2010 Diabetes, 
Asthma, 
Hypertension, 
Heart Failure 
Up. Diabetes: trend towards better glycaemic control. 
Asthma significant improvement in PEF, significant 
reductions in symptoms, improvement in perceived qol.  
Hypertension - better control of blood pressure. 
Not Assessed   
Polisena, et al 2010 Coronary Not Assessed Neutral. Quality of life: 7 
studies reported no 
difference in QoL. 5 
studies reported 
increased QoL and 
satisfaction in the 
interventions 
  
Polisena, et al 2010 COPD Not Assessed Neutral. Quality of life: 2 
studies reported no 
difference in QoL. 2 
studies reported 
increased QoL and 
satisfaction in the 
interventions 
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Author Title Year Aims Findings 
Ando et al Feasibility 
Evaluation of a 
remote monitoring 
system for 
implantable 
cardiac devices in 
Japan. A 
prospective 
analysis 
2010 To analyse the acceptance of 
cardiac device remote 
monitoring in Japan 
More than 87% of the subjects felt the Monitor was easy to use, the 
majority felt reassured by having their devices monitored, and preferred 
the decreased clinic visits. Nearly all the physicians were satisfied with 
the system. However the Japanese context may be different than the 
UK. 
Jones et al Patients' 
experiences of 
self-monitoring 
blood pressure 
and self-titration of 
medication; the 
TASMINH2 trial 
qualitative study 
 
2012 To explore patients views of 
self-monitoring blood pressure 
and self-titration of anti-
hypertensive medication. 
Patients were confident about self-monitoring and many felt their multiple 
home readings were more valid than a single reading taken by their GP. 
Although some patients were confident to adjust their medication based 
on results, many lacked the confidence without a consultation with their 
GP, especially if results were borderline. Many planned to continue self-
monitoring but few wished to continue self-management plan. 
Martínez-
Sarriegui I, 
et al 
How Continuous 
Monitoring 
Changes the 
Interaction of 
Patients with a 
Mobile 
Telemedicine 
System 
2011 To analyse patients’ behaviour 
from the use-of-the-system 
point of view, identifying how 
system monitoring may change 
the interaction of patients with 
the mobile telemedicine system. 
Subjective evaluation showed that patients would recommend the 
DIABTel in routine care. The use of a glucose monitor changes the way 
that patients manage their diabetes. Continuous monitoring also 
increases the interaction of patients with the information system and 
modifies their pattern of use.  Mobile technologies are especially useful 
where close monitoring of diabetes in necessary.  They are well 
accepted by patients. 
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Rogers A, 
Kirk S, 
Gately  C, 
May C.R, 
Finch T 
Established users 
and the making of 
telecare work in 
long term 
condition 
management 
2011 To illuminate how people 
experience, understand and 
negotiate 
the transfer of technologies into 
their homes. 
b) To examine the extent to 
which telecare systems are 
incorporated 
into the life world of patients 
and carers and the factors 
that promote or inhibit 
integration. 
This robust  research suggests that, telecare services provide both an 
adequate substitution for traditional services and additional benefits such 
as minimising the need to travel and the added reassurance of regular 
external surveillance. However, the nature of patient work involved is 
‘low level’ rather than requiring higher level interpretation of readings and 
decision making commensurate with realising a policy vision of more 
independent and responsible self managers. Indeed a paradox of the 
reliance and acceptance of telecare is the creation of new relationships 
and dependencies rather than the diminution of reliance envisaged by 
policy. 
Seto E , 
Leonard 
K.J, 
Cafazzo 
J.A, 
Barnsley J, 
Masino C 
and Ross 
H.J  
Perceptions and 
Experiences of 
Heart Failure 
Patients and 
Clinicians on the 
Use of Mobile 
Phone-Based 
Telemonitoring 
2012 To provide in-depth insight into 
the effects of telemonitoring on 
self-care and clinical 
management, and  to determine 
the features that enable 
successful heart failure 
telemonitoring. 
1) Improved patient self-care 2) Ptns more aware of condition, less 
anxious and more empowered 3) More effective monitoring of condition 
by clinicians 4) Clinical concerns re. on-going costs of telemedicine 
system 5) Clinical concerns re. increased workload   6) Few patients 
didn't want to be monitored long term whilst a few worried regarding 
dependency on the system. 
 
Table 4: Qualitative studies of patient experience 
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Appendix One:  Search strategies 
MEDLINE – OVID.  Conducted 2 October 2012 
1. exp Telemedicine/ 
2. telehealth*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
protocol supplementary concept, rare disease supplementary concept, unique identifier] 
3. 1 or 2 
4. Chronic Disease/ 
5. Long-Term Care/ 
6. Self Care/ 
7. Disease Management/ 
8. Community Health Nursing/ 
9. long term condition*.mp. [mp=title, abstract, original title, name of substance word, subject heading 
word, protocol supplementary concept, rare disease supplementary concept, unique identifier] 
10. exp Diabetes Mellitus/ 
11. exp Pulmonary Disease, Chronic Obstructive/ 
12. exp cardiovascular diseases/ or heart failure/ 
13. exp Kidney Diseases/ 
14. exp Renal Replacement Therapy/ 
15. exp Asthma/ 
16. exp Dementia/ 
17. exp cerebrovascular disorders/ or stroke/ 
18. exp Nervous System Diseases/ 
19. cystic fibrosis/ or exp respiratory tract diseases/ or exp cardiovascular diseases/ 
20. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
21. 3 and 20 
22. limit 21 to yr="2000 -Current" 
23. limit 22 to (english and (clinical trial, all or clinical trial, phase i or clinical trial, phase ii or clinical trial, 
phase iii or clinical trial, phase iv or clinical trial or comparative study or controlled clinical trial or 
evaluation studies or meta analysis or practice guideline or randomized controlled trial or "review" or 
"scientific integrity review" or validation studies)) 
24. exp HIV/ 
25. exp HIV Infections/ 
26. 20 or 24 or 25 
27. 3 and 26 
28. 22 and 23 and 27 
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Cinahl – EBSCO interface.  Conducted 2 October 2012 
 
 
#  Query  
S36  S19 and S34  
S35  S19 and S34  
S34  
S20 or S21 or S22 
or S23 or S24 or 
S25 or S26 or S27 
or S28 or S29 or 
S30 or S31 or S32 
or S33  
S33  "Respiratory diseases"  
S32  
(MH "Human 
Immunodeficiency 
Virus")  
S31  
(MH "Nervous 
System 
Diseases+")  
S30  (MH "Dementia+")  
S29  (MH "Kidney Diseases+")  
S28  
(MH 
"Cardiovascular 
Diseases+")  
S27  (MH "Respiratory Tract Diseases+")  
S26  
(MH 
"Demyelinating 
Autoimmune 
Diseases, CNS")  
S25  (MH "Diabetes Mellitus+")  
S24  (MH "Community Health Nursing+")  
S23  (MH "Disease Management")  
S22  (MH "Self Care+")  
S21  
(MH "Long Term 
Care") OR "long 
term condition" OR 
0
21  
(MH "Nursing 
Home Patients")  
S20  (MH "Chronic Disease")  
S19  
(MH "Telehealth+") 
OR (MH 
"Telemedicine+")  
S18  S1 and S16  
S17  S1 and S16  
S16  
S2 or S3 or S4 or 
S5 or S6 or S7 or 
S8 or S9 or S10 or 
S11 or S12 or S13 
or S14 or S15  
S15  "Respiratory diseases"  
S14  
(MH "Human 
Immunodeficiency 
Virus")  
S13  
(MH "Nervous 
System 
Diseases+")  
S12  (MH "Dementia+")  
S11  (MH "Kidney Diseases+")  
S10  
(MH 
"Cardiovascular 
Diseases+")  
S9  (MH "Respiratory Tract Diseases+")  
S8  
(MH 
"Demyelinating 
Autoimmune 
Diseases, CNS")  
S7  (MH "Diabetes Mellitus+")  
S6  (MH "Community Health Nursing+")  
S5  (MH "Disease Management")  
S4  (MH "Self Care+")  
S3  (MH "Long Term 
22  
Care") OR "long 
term condition" OR 
(MH "Nursing 
Home Patients")  
S2  (MH "Chronic Disease")  
S1  
(MH "Telehealth+") 
OR (MH 
"Telemedicine+")  
 
 
Health Services Management Consortium Database (HMIC). Conducted 2 
October 2012  
 
1. telehealth/ or telemedicine/ or medical telemetering equipment/ or telecare/ or telemetry/ 
2. "chronic disease AND/OR Chronic illness"/ 
3. long term care/ or long term care charters/ or exp chronic disease/ or exp chronic illness/ 
4."chronic disease AND/OR Chronic illness"/ 
5. long term treatment/ 
6. exp Self care/ 
7. exp Disease management/ 
8. community health care/ or community mental health care/ or community nursing/ 
9.exp Diabetes/ 
10. exp respiratory tract diseases/ 
11. exp cardiovascular diseases/ 
12. exp urologic diseases/ 
13. exp asthma/ 
14. exp nervous system diseases/ 
15. vascular diseases/ or stroke/ 
16. hiv/ 
17. 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 
18. 1 and 17 
      limit 18 to yr="2000 - 2013 
  
23  
Web of Knowledge.  Conducted 5 October 2012 
 
Topic = (telehealth* OR telemedicine*) AND Topic=((chronic disease* OR long term 
care OR self care OR disease manage* OR community health nurs* OR long term 
condit* OR diabetes* OR pulmonary dis* OR COPD OR cardiovascular OR heart 
failure OR kidney OR renal OR asthma* OR dementia OR cerebrovascular OR 
stroke OR nervous system OR cystic fibrosis OR respiratory tract OR HIV))  
Refined by: Document Types=( CLINICAL TRIAL OR REVIEW )  
Time span=2000-2012.  
Search language=Auto   Lemmatization=On    
 
NHS Evidence. Conducted 5 October 2012 
telehealth* OR telemedicine* 
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Appendix Two – Overview Table 
 
Author Title Year Source Aims/objectives of paper Number of 
studies in 
review 
Length of 
studies in 
review 
Key findings 
Abudagga, A., 
Resnick, H.E. & 
Alwan, M. 
Impact on 
Blood 
Pressure 
Telemonitoring 
on 
Hypertension 
Outcomes: A 
literature 
review 
2010 Telemedicine 
and e-Health 
Explore the 
effectiveness of BP 
telemonitoring on BP 
control and other 
outcomes targeting 
patients with 
hypertension as a 
primary diagnosis  
15 2-24 months Telemonitoring resulted in a reduction of BP in all but 2 studies (13/15). 
Systolic BP declined by 3.9- 13mm Hg and diastolic declined by between 2 - 8 
mmHg. Compliance with telemonitoring was good among patients but less well 
documented in healthcare providers. .  
Anker, S.D., 
Koehler, F., & 
Abraham, W.T. 
Telemedicine 
and remote 
management 
of patients with 
heart failure. 
2011 Lancet Summarise the available 
telemedicine 
interventions in heart 
failure. Discus the 
systematic differences 
between reported trials 
and suggest a 
classification system for 
trials of TM and remote 
management.  
4 meta-
analyses, 4 
RCTs 
Not stated This paper summarises recent meta-analyses in which the outcome measures 
of admission and death were reduced following telemonitoring. The paper 
presents recent RCTs that offer findings suggesting no differences apart from 
one invasive study in which admissions and length of stay was reduced.  
Bolton, C.E., 
Waters, C.S., 
Peirce, S., & 
Elwyn, G. 
Insufficient 
evidence of 
benefit; a 
systematic 
review of 
home 
telemonitoring 
for coped 
2011 Journal of 
Evaluation in 
Clinical 
Practice 
Examine the evidence of 
Tm for patients with 
COPD.  
6 3-12 months Positive results of TM in managing COPD. However due to the risk of bias in 
the design of studies the conclusion is that the benefit of TM in managing 
COPD is not yet proven and further work is required.  
Clarke, M, Shah, 
A., & Sharma, U. 
Systematic 
review of 
studies on 
telemonitoring 
of patients with 
congestive 
heart failure: a 
meta-analysis 
2011 Journal of 
telemedicine 
and telecare 
Evaluate the 
effectiveness of 
telemonitoring on 
patients with congestive 
heart failure 
13 3-15 months There was an overall reduction in all cause mortality. There was no reduction 
in all cause admission although a reduction in CHF admission. There was no 
difference in length of stay, medication adherence or cost. Telemonitoring in 
conjunction with nurse home visits and specialising unit support can be 
effective in the management of CHF patients to improve quality of life.  
de Waure, C., 
Caeddu, C., 
Gualano, M.R., 
Ricciardi, W. 
Telemedicine 
for the 
reduction of 
myocardial 
2012 Telemedicine 
and e-Health 
Assess how 
telemedicine systems 
including early telemetry 
of ECG can improve 
5 Not stated All studies demonstrated the effectiveness of TM. 3 studies suitable for meta-
analysis showed that relative risk for in-hospital mortality was 0.65 in the TM 
group. 
25  
infarction 
mortality: A 
systematic 
review and a 
meta-analysis 
of publishes 
studies 
health outcomes in 
patients with coronary 
artery disease, in 
particular acute 
myocardial infarction. 
Ekeland, A.G., 
Bowes, A. & 
Flottorp, S.  
Methodologies 
for assessing 
telemedicine: 
A systematic 
review of 
reviews 
2012 International 
journal of 
medical 
informatics 
To summarise the 
methodologies used in 
telemedicine research, 
discuss knowledge gaps 
and recommendations 
and suggest 
methodological 
approaches for future 
research 
21 reviews Not stated One group recommended larger and more rigorously designed controlled 
studies to assess the impacts of telemedicine. A second group proposed 
standardisation of populations and/or outcome measures to reduce 
heterogeneity and facilitate meta-analysis. A third group recommended 
combining quantitative and qualitative research methods. Other groups called 
for naturalistic approaches including methodologies addressing mutual 
adaptations of services and users also politically driven action research and 
formative research aimed at collaboration to ensure improvement in natural 
settings. 
Ekeland, A.G., 
Bowes, A. & 
Flottorp, S.  
Effectiveness 
of 
telemedicine 
2010 International 
Journal of 
Medical 
Informatics 
To report on a review of 
reviews on the impacts 
and costs of 
telemedicine services 
80 reviews Not stated 80 systematic reviews were included.  21 concluded telemedicine is effective, 
18 that it is promising.  Emerging themes are that economic analyses are 
problematic, the benefits of telemedicine for patients and telemedicine is a 
complex intervention and has unpredictable processes.  There is a need for 
larger studies as controlled interventions.  New evaluations should focus on 
patients perspectives, economic analyses and ongoing collaborative 
achievements.  Formative assessments are emerging as an area of interest. 
Holtz, B & 
lauckner, C. 
Diabetes 
management 
via mobile 
phones 
2012 Telemedicine 
and E-health 
Understand the most 
common uses and 
functions of mobile 
phones in monitoring 
and managing diabetes, 
their potential role in a 
clinical setting and the 
current state of 
research.  
21 2wks-12 
months 
The studies reviewed demonstrated promise in using mobile phones to help 
people manage their diabetes condition effectively.  
Inglis, S.C.,Clark, 
R. A, McAlister, F. 
A., Stewart, S, 
and Cleland, J. G. 
F. 
Which 
components of 
heart failure 
programmes 
are effective?  
2011 European 
Journal of 
Heart Failure 
Review randomized 
controlled trials (RCTs) 
of Telemonitoring or 
Structured telephone 
support for all-cause 
mortality and all-cause 
and CHF-related 
hospitalisations in 
patients with CHF, as a 
non-invasive remote 
model of a specialized 
disease-management 
intervention. 
14 3-18 months A systematic review and meta-analysis of the outcomes of structured 
telephone support or telemonitoring as the primary component of chronic heart 
failure management in 8323 patients: Abridged Cochrane Review 
 
Telemonitoring and STS both appear effective interventions to improve 
outcomes in patients with CHF. 
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Kraai, I.H., Luttik, 
M.L.A., De Jong, 
R.M., Jaarsma, 
T., & Hillege, H.L. 
Heart failure 
patients 
monitored with 
telemedicine: 
Patient 
satisfaction, a 
review of the 
literature 
2011 Journal of 
Cardiac 
Failure 
Describe the current 
state of the literature on 
patient satisfaction with 
non-invasive 
telemedicine, regarding 
definition, measurement 
and overall level of 
patient satisfaction with 
telemedicine. 
14 Not stated Patients seem to be satisfied or very satisfied with the use of telemedicine. 
Measurement of patient satisfaction is still underexposed in telemedicine 
research and the measurement is under appreciated with poorly constructed 
questionnaires. 
McLean et al 
 
McLean S, 
Chandler D, 
Nurmatov U, Liu 
J, Pagliari C, Car 
J, Sheikh A. 
Telehealthcare 
for asthma: a 
Cochrane 
review 
 
Telehealthcare 
for Asthma 
(intervention 
review) 
2011 
 
 
 
 
2010 
Canadian 
Medical 
Association 
Journal 
 
The 
Cochrane 
Library 
A systematic review of 
studies of telehealthcare 
interventions used for 
the treatment of asthma 
to determine whether 
such approaches to care 
are effective. 
21 3-12 months We found no evidence of a clinically important impact on patients’ quality of life 
nor A&E visits, but telehealthcare interventions do appear to have the potential 
to reduce the risk of admission to hospital, particularly for patients with severe 
asthma. Further research is required to clarify the cost -effectiveness of 
models of care based on telehealthcare. 
 
Significant reduction in hospital admissions, especially in patients with severe 
asthma. No improvement in quality of life, and no reduction in A&E admissions 
McLean, S. 
Nurmatov, U, Liu, 
JLY, Pagliari, C. 
Car, J., & Sheikh, 
A. 
Telehealthcare 
for chronic 
obstructive 
pulmonary 
disease 
(review) 
2011 Cochrane 
database for 
systematic 
reviews 
Review the effectiveness 
of telehealthcare for 
COPD compared with 
face to face care 
10 Not stated Increased quality of life. Reduction in attendances to emergency departments. 
There was no difference in the odds ratio for deaths compared to usual care. 
MCLean, S., 
Protti, D., Sheikh, 
A. 
Telehealthcare 
for long term 
conditions 
2011 BMJ Clinical review of 
telehealthcare for long 
term conditions: clinical 
relevance and 
application of the 
findings 
Not stated Not stated Overview paper based on reviews stated above. In patients with severe long 
term conditions such as problematic asthma and diabetes, telehealthcare can 
reduce hospital admissions without increasing mortality. Potential pitfalls 
include: user interface problems, technical problems, and safety concerns 
such as data loss and confidentiality. May alter doctor-patient relationship - 
thus healthcare professionals need to try and humanise the interaction. 
Careful assessment of effectiveness, cost-effectiveness and safety 
consideration is needed before introducing into any practice. 
Omboni, S & 
Guarda, A.  
Impact of 
Home blood 
pressure 
telemonitoring 
and blood 
pressure: a 
meta-analysis 
or randomized 
controlled 
trials 
2011 American 
Journal of 
Hypertension 
Summarise the 
effectiveness of home 
telemonitoring on blood 
pressure control from 
randomised controlled 
studies.  
10 2-240 weeks Home blood pressure telemonitoring may represent a useful tool to improve 
blood pressure control. Heterogeneity of published studies suggest a need for 
more large scale RCTs to demonstrate the usefulness.  
Pare et al Clinical effects 
of home 
telemonitoring 
2010 Journal of 
Medical 
Internet 
To conduct a systematic 
review to understand the 
clinical effects 
62 Not stated 1. Studies for diabetes showed a trend towards achieving better glycemic 
control with telemonitoring.  2. Studies for asthma showed significant 
improvements in peak expiratory flows, significant reductions in symptoms and 
27  
in the context 
of diabetes, 
asthma, heart 
falure and 
hypertension: 
a systematic 
review 
research associated with home 
telemonitoring programs 
in the context of 4 
chronic diseases. 
improvements in perceived qol.  Hypertension studies showed for the majority 
that home telemonitoring reduced systolic and or/diasistolic blood pressure.  
Findings for patients with heart failure were equivacol and larger trials are 
needed.  Future studies need a better means of controlling mediating 
variables.  Suggests a range of critical success factors when using telehealth 
applications.  Telehealth doesn’t appear to be suited to everyone, beneficial 
effects are mainly amongst patients whose health condition appears serious 
and the patients are keen to play an active role in the management of their 
illness or where the patients are interested in using this kind of system.  The 
user friendliness of the device are an important acceptance criteria for patients 
and different types of systems a 
Polisena, J., Tran, 
K. Cimon, K. 
Brian, H. McGill, 
S. Palmer, K., & 
Scott, R.E 
Home 
telemonitoring 
for congestive 
heart failure: a 
systematic 
review and 
meta-analysis.  
2010 Journal of 
telemedicine 
and telecare 
Evaluate the 
effectiveness of 
telemonitoring on 
patients with congestive 
heart failure 
22 1-12 months Home telemonitoring reduced mortality compared to usual care. Several 
studies suggested that home monitoring helped lower hospitalisations. Quality 
of life was similar or better that without no TM. More studies of better quality 
are required. 
Polisena, J., Tran, 
K. Cimon, K. 
Brian, H. McGill, 
S. Palmer, K., & 
Scott, R.E 
Home 
Telehealth fo 
chronic 
obstructive 
pulmonary 
disease: a 
Systematic 
review and 
meta analysis. 
2010 Journal of 
telemedicine 
and telecare 
Compare home 
telehealth for COPD with 
usual care. 
10 3-12 months Home telehealth was found to reduce rates of hospitalisation and emergency 
department visits. Bed days varied. Mortality rate was greater in the telephone 
support group compared to usual care . Home telehealth interventions were 
similar or better than usual care for quality of life and patient satisfaction.  
Wootton Twenty years 
of 
telemedicine in 
chronic 
disease 
management: 
an evidence 
synthesis 
2012 Journal of 
Telemedicine 
and Telecare 
To provide a high level 
view of the value of 
telemedicine in the 
management of 5 
common chronic 
diseases (asthma, 
COPD, diabetes, heart 
failure, hypertension) 
141 Not stated 108 studies show positive effects whilst only 2 show negative effects, 
suggesting an element of publication bias.  There appears to be no significant 
difference between the diseases, ie telemedicine is equally effective (or 
ineffective) for all the diseases studied.  Half the systematic reviews reported 
showed significantly better outcomes than control and other half showed no 
difference.  Earlier studies tend to be more positive.  Most studies have a short 
term follow up (6 months) which is unlikely to be useful when studying a long 
term chronic disease.  Suggests the evidence based for the value of 
telemedicine in chronic diseases is weak and contradictory.  Suggests that 
most studies of telemedicine report positive effect due to the Hawthorne effect. 
Suggests the need for a minimum data set for future studies so that 
comparisons can be made. 
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Glossary and explanation of terms:   
 
Some of the common terms and techniques which are used throughout this report 
are explained below. 
 
Systematic review = a rigorous review of primary research studies on a particular 
topic area.  The methods used to conduct the review are made explicit and the 
papers included are examined in an unbiased way according to a set of pre-
established criteria.  Viewed as the “gold standard” means of providing the best 
evidence available. 
 
Meta-analysis = Technique which statistically combines the outcomes of multiple 
studies to show the effect of an intervention.  Often used in conjunction with 
systematic reviews. Overcomes problems with small sample sizes but can only be 
conducted with studies with comparable outcomes.  Because many of the studies 
within the reviews included here were very different and compared different 
outcomes, some reviews have not included meta-analyses or only conducted meta-
analyses on a limited number of outcomes. 
 
RR=Risk ratio or relative risk.  A method of comparing outcomes between an 
intervention and control group to demonstrate whether an intervention has had an 
effect (or not).  If the intervention and control conditions have the same effect, then 
(assuming the groups are comparable in all other respects) the risk of the event (eg, 
death) will be the same in both groups, and the RR will be 1.0. If the risk of death is 
reduced in the intervention group compared with the control group, then the RR will 
be less than<1.0. If, however, the intervention is harmful, then the RR will be greater 
than >1.0. The further away the RR is from 1.0, the greater the strength of the 
association between the intervention and the outcome. 
 
OR = Odds ratio.  An alternative method of comparing outcomes between an 
intervention and control group based on odds or probabilty.  An OR of 1.0 means 
there is no difference between the groups and an OR less than <1.0 means that the 
event is less likely in the intervention group than the control group.  
 
Both risk ratios and odds ratios assess statistical significance rather than actual 
clinical significance, ie they demonstrate  relative differences rather than the actual 
effect in clinical terms. 
 
Relative and absolute differences in risk can each be expressed in 4 different ways, 
depending on the outcome measured (“good” event or “bad” event) and the direction 
of effect. A risk reduction occurs when the risk of a bad event decreases. A benefit 
increase occurs when the risk of a good event increases. A risk increase occurs 
when the risk of a bad event increases, and a benefit reduction occurs when the risk 
of a good event decreases. 
 
RCT – Randomised controlled trial.  An experimental study which compares two or 
more interventions in an unbiased way.  Viewed as the gold standard method of 
assessing effectiveness of an intervention.  However not always feasible to conduct 
when an intervention has lots of variables which need to be controlled or operates in 
multiple contexts. 
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